Your browser doesn't support javascript.
loading
Ascites-derived pancreatic ductal adenocarcinoma primary cell cultures as a platform for personalised medicine.
Golan, T; Atias, D; Barshack, I; Avivi, C; Goldstein, R S; Berger, R.
  • Golan T; 1] Institute of Oncology, Sheba Medical Center, Tel Hashomer 52621, Israel [2] Sackler School of Medicine, Tel Aviv University, Ramat Aviv 69978, Israel.
  • Atias D; Institute of Oncology, Sheba Medical Center, Tel Hashomer 52621, Israel.
  • Barshack I; Department of Pathology, Sheba Medical Center, Tel Hashomer 52621, Israel.
  • Avivi C; Department of Pathology, Sheba Medical Center, Tel Hashomer 52621, Israel.
  • Goldstein RS; Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan 52900, Israel.
  • Berger R; 1] Institute of Oncology, Sheba Medical Center, Tel Hashomer 52621, Israel [2] Sackler School of Medicine, Tel Aviv University, Ramat Aviv 69978, Israel.
Br J Cancer ; 110(9): 2269-76, 2014 Apr 29.
Article en En | MEDLINE | ID: mdl-24667644

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Ascitis / Líquido Ascítico / Carcinoma Ductal Pancreático / Ensayos Antitumor por Modelo de Xenoinjerto / Medicina de Precisión / Cultivo Primario de Células Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2014 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Ascitis / Líquido Ascítico / Carcinoma Ductal Pancreático / Ensayos Antitumor por Modelo de Xenoinjerto / Medicina de Precisión / Cultivo Primario de Células Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2014 Tipo del documento: Article